Only show
results from:

Sort results by:

Display preferences
7,224 results sorted by relevancy Results per page:
MGI PHARMA to Present at the UBS 2005 Global Life Sciences Conference.
Business Wire; Sep 20, 2005; 700+ Words ...MINNEAPOLIS -- MGI PHARMA, INC. (Nasdaq:MOGN...September 27, at 1:00 p.m. Eastern Time...executive officer of MGI PHARMA, will give the presentation...2005 at 1:00 p.m. Eastern Time...week. About MGI PHARMA MGI PHARMA, INC. is an oncology...
MGI PHARMA And Alpharma Enter into Promotion Agreement for Kadian in Cancer Pain.
Business Wire; Jul 14, 2004; 700+ Words ...commercial development at MGI PHARMA. "The convenience of...patients' pain." MGI PHARMA will broadcast its quarterly...July 14, 2004 at 1:00 p.m. Eastern Time. The...provide guidance on MGI PHARMA's business outlook...MGI PHARMA MGI PHARMA, INC. is an oncology-focused...
MGI PHARMA Announces Commencement of Tender Offer for Guilford Pharmaceutical Notes Due 2008.
Business Wire; Oct 20, 2005; 700+ Words ...Guilford Pharmaceuticals Inc. on October 3, 2005...were issued. MGI PHARMA estimates that the...6772 shares of MGI PHARMA common stock, and...expires at 5:00 p.m. New York City...Morrow & Co., Inc., information agent...com. About MGI PHARMA MGI PHARMA, INC...
U3 Pharma AG Raises Euro 27 Million in Third Round of Private Equity Led by LSP.
PR Newswire; May 22, 2006; 700+ Words ...Managing Partner, Alta Partners Inc. About U3 Pharma U3 Pharma AG is an emerging...Managing Director, CBO of U3 Pharma AG, +49 (0)171 493 8881...u3pharma.com; or Gretchen L.P. Schweitzer for U3 Pharma AG, +49 (0)89 450 29741...
PHARMA PATCH PLC ENTERS INTO AGREEMENT WITH REVLON FOR EVALUATION OF PROPRIETARY SKIN PENETRATION ENHANCER TECHNOLOGIES IN COSMETICS
PR Newswire; Jul 12, 1994; 700+ Words ...developed by Revlon with Pharma Patch's assistance...permeability of the skin. Pharma Patch has a broad family...Revlon Research Center, Inc. said "this agreement with Pharma Patch has the potential...subsidiary of Recordati, S.p.A, one of Italy...
MGI PHARMA Announces 2-for-1 Stock Split, Results of Annual Shareholder Meeting.
Business Wire; May 11, 2004; 700+ Words ...which is the date MGI PHARMA's common shares will...adjusted price. MGI PHARMA also announced the results...was held today at 1:00 p.m. CST in Minneapolis...was ratified. About MGI PHARMA MGI PHARMA, INC. is an oncology-focused...
MGI PHARMA First Quarter 2005 Financial Results Conference Call to Be Webcast on April 13, 2005.
Business Wire; Apr 6, 2005; 700+ Words ...MINNEAPOLIS -- MGI PHARMA, INC. (Nasdaq:MOGN...2005 at 5:00 p.m. Eastern Time...president and CEO of MGI PHARMA, and members of...2005 at 5:00 p.m. Eastern Time...month. About MGI PHARMA MGI PHARMA, INC. is an oncology...
Antares Pharma, Inc. Licenses Rights to Hormone Product to BioSante Pharmaceuticals, Inc. Market For Hormone Replacement Therapy Products Exceeds $2.5 Billion in U.S.
PR Newswire; Jan 8, 2002; 700+ Words EXTON, Pa. -- Antares Pharma, Inc. today announced a license agreement...fruitful relationship with Antares Pharma." Bioinnovators, Inc., a pharmaceutical industry consulting...and Exchange Commission. Antares Pharma claims the p
65-0: OxyContin(R) Cases Against Purdue Pharma Dismissed at Record Rate; 16 dismissals in 2 months leave dockets clear in Arizona, California, Hawaii, Maine, North Carolina, Utah, Vermont.
PR Newswire; Dec 1, 2003; 700+ Words ...Mathis v. Purdue Pharma L.P., et al; Louisiana: Arceneaux v. Purdue Pharma L.P., Fontenot v. Able Laboratories, Inc., et al, Strickland v. Purdue Pharma L.P., et al; Mississippi: McGee...
MGI PHARMA Second Quarter 2005 Financial Results Conference Call to Be Webcast on July 13, 2005.
Business Wire; Jul 6, 2005; 700+ Words ...MINNEAPOLIS -- MGI PHARMA, INC. (Nasdaq:MOGN...2005 at 5:00 p.m. ET. Lonnie...executive officer of MGI PHARMA, and other members...2005 at 5:00 p.m. ET How: Live...week. About MGI PHARMA MGI PHARMA, INC. is an oncology...
MGI PHARMA and Guilford Pharmaceuticals Announce Expiration of the Hart-Scott-Rodino Waiting Period.
Business Wire; Sep 1, 2005; 700+ Words ...MINNEAPOLIS & BALTIMORE -- MGI PHARMA, INC. (Nasdaq:MOGN), an oncology...and Guilford Pharmaceuticals Inc. (Nasdaq:GLFD), a biopharmaceutical...acquisition of Guilford by MGI PHARMA, expired at 11:59 p.m. Eastern Time on August 31...
Debiopharm S.A. Announces the Purchase of all Outstanding Shares of H3 Pharma.
PR Newswire; Mar 1, 2005; 700+ Words ...development company in the pharma industry. We look forward...Debioinnovation, Debio R.P. and Debioclinic. Debiopharm...kbill@debio.com; H3 Pharma Contacts, Dr Loic Maurel, President and CEO, H3 Pharma Inc., Phone: +1-514...
PHARMA PATCH PLC. ANNOUNCES THE FILING OF A SECURITIES EXCHANGE TAKEOVER BID CIRCULAR TO ACQUIRE ALL COMMON SHARES OF CANGENE CORPORATION
PR Newswire; Jun 29, 1994; 700+ Words ...Cangene on June 29, 1994. Pharma Patch is offering the...one ordinary share of Pharma Patch, represented by...acceptance until 4:30 p.m. (Vancouver time...extended. ScotiaMcLeod Inc. has been retained to...been engaged to act as Pharma Patch's financial advisor...
Antares Pharma's Licensee Announces First Transdermal Estradiol Gel With Three Doses That Significantly Decrease Hot Flashes in Menopausal Women.
PR Newswire; Sep 30, 2005; 700+ Words ...FirstCall/ -- Antares Pharma, Inc. announced today that...BioSante Pharmaceuticals, Inc. has presented a full...6 after treatment (p<0.0001...1 with placebo (p<0.0001...utilizes Antares Pharma's proprietary Advanced...
Dr. James Armitage Appointed to MGI PHARMA Board of Directors.
Business Wire; Jul 26, 2006; 700+ Words MINNEAPOLIS -- MGI PHARMA, INC. (Nasdaq:MOGN), a biopharmaceutical...Armitage, M.D., F.A.C.P., F.R.C.P., has been appointed to the MGI PHARMA Board of Directors. Dr...About MGI PHARMA MGI PHARMA, INC. is a biopharmaceutical...
MGI PHARMA Analyst and Institutional Investor Event to Be Webcast on May 25, 2005.
Business Wire; May 18, 2005; 700+ Words ...MINNEAPOLIS -- MGI PHARMA, INC. (Nasdaq:MOGN...approximately 12:00 p.m. ET. Lonnie...executive officer of MGI PHARMA, and several members...approximately 12:00 p.m. ET How: Live...month. About MGI PHARMA MGI PHARMA, INC. is an oncology...
MGI PHARMA to Present at the BIO CEO and Investor Conference.
Business Wire; Feb 7, 2006; 700+ Words ...MINNEAPOLIS -- MGI PHARMA, INC. (Nasdaq:MOGN...2006 at 3:00 p.m. Eastern Time...Executive Officer of MGI PHARMA, will give the presentation...2006 at 3:00 p.m. Eastern Time...week. About MGI PHARMA MGI PHARMA, INC. is an oncology...
Antares Pharma to Present at BioContact Conference in Quebec, Canada.
PR Newswire; Sep 29, 2005; 700+ Words ...FirstCall/ -- Antares Pharma, Inc. , an evolving specialty...October 5, 2005 at 4:30 p.m. Eastern Time...Canada to present Antares Pharma to the growing healthcare...Europe. About Antares Pharma Antares Pharma is a specialized...
MGI PHARMA Updates Outlook for First Quarter.
Business Wire; Apr 13, 2006; 700+ Words ...Executive Officer of MGI PHARMA. "We continue to believe...results news release. MGI PHARMA's first quarter 2006...the Internet at 5:00 p.m. ET on April 19...for one week. About MGI PHARMA MGI PHARMA, INC. is an oncology- and...
Pharma cos sip into RTD segment.
Economic Times (New Delhi, India); Jun 11, 2006; 700+ Words ...players include Merck India's Electrobion, CFL Pharma's Coslyte, Wallace Pharma's Wlayte-P, FDC's Punarjal, Shreya Life Sciences...among others. Recently, Delhi-based Mankind Pharma joined the fray with its ORS brand Electrokind...
7,224 results: 1 | 2 | 3 | 4 | 5 | Next >>

Find articles, research, and archives